Pharmuna, an AI-powered pharmacy platform designed to make medical and medication-related guidance more accessible, has raised US$5 million through FasterCapital. The company had previously secured US$200,000 in investment to support its initial development and growth. FasterCapital led the round, multiple venture capital firms participated, and FasterCapital CEO Hesham Zreik invested personally as lead investor.
Funding Details and Investor Support
FasterCapital is supporting Pharmuna through its Raise Capital program and broader venture-building services. The assistance covers fundraising preparation, investor outreach, business development, product strategy, international expansion, and strategic advisory. As lead investor, Hesham Zreik will also work with the Pharmuna team on strategic direction and fundraising efforts while FasterCapital leverages its investor network to connect the company with additional investors and strategic partners.
Addressing a Healthcare Information Gap
Pharmuna was created to address a common challenge in healthcare: important questions about medicines, side effects, drug interactions, dosage instructions, and treatment options often lack immediately available reliable guidance. Patients may leave a clinic or pharmacy with unanswered questions, while online searches can return fragmented, highly technical, or unreliable information. The platform aims to create a clearer first point of access to healthcare and pharmacy-related information.
Responsible AI and Human Expertise
The platform uses artificial intelligence to provide users with immediate, easy-to-understand preliminary guidance about medications and general healthcare concerns. It can help users better understand medicine-related information, identify questions to discuss with a healthcare professional, and recognize situations that require professional medical advice. Pharmuna is designed to support, rather than replace, doctors, pharmacists, and other healthcare professionals by connecting users with qualified providers when needed.
Strategic Growth Plans
With the new funding, Pharmuna plans to further develop its AI-powered guidance technology and expand its healthcare professional and pharmacy network. The company will enhance medication and drug-interaction information, strengthen its user experience, and enter additional international markets. Pharmuna also plans to further develop safeguards and escalation mechanisms that encourage users to seek professional medical care whenever individualized diagnosis, treatment, or medical judgment is required.
Investor Commentary
FasterCapital CEO Hesham Zreik said he decided to invest in Pharmuna because the startup addresses an important and widespread healthcare problem. He noted that people increasingly expect immediate access to information, but healthcare requires a more responsible approach than most other industries. Zreik added that Pharmuna combines the speed and accessibility of AI with the essential judgment and expertise of qualified healthcare professionals.
Founder Perspective
Pharmuna Founder and CEO Clara Nyto said people often have important questions about their medicines and health but do not always have quick access to clear and reliable guidance. She explained that Pharmuna was created to bridge that gap by using AI responsibly while keeping qualified healthcare professionals central to medical decisions. Nyto added that the US$5 million round, together with the investment and support of Hesham Zreik and FasterCapital, will help improve its technology, expand its professional network, and reach more users.
About FasterCapital
FasterCapital is an online incubator, accelerator, and venture builder based in Dubai, UAE. Established in 2014, the organization supports entrepreneurs through fundraising, technical development, business growth, market expansion, idea validation, and strategic advisory. FasterCapital has supported over 1,697 startups in raising more than US$2.8 billion and has directly invested more than US$1.27 billion in 1,193 companies.
Pharmuna’s latest funding round positions the company to expand its AI-powered pharmacy platform while maintaining a strong emphasis on professional medical oversight. The startup aims to reduce fragmentation for users seeking medical information and professional support by creating stronger connections between patients, pharmacies, healthcare professionals, and specialized providers. With FasterCapital’s venture-building support and investor network, Pharmuna is preparing to scale its technology and reach new markets.